LBA25 FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer

N.A. Dasari, Sara Lonardi, Rocio García‐Carbonero, M.E. Elez Fernandez, Takashi Yoshino, Alberto Sobrero, J.C. Yao, Pilar García‐Alfonso, Judit Kocsis, Antonio Cubillo Gracián, Andrea Sartore‐Bianchi, Takeshi Satoh, Violaine Randrian, Jiří Tomášek, Geoffrey Chong, Z. Yang, W. Schelman, M. Kania, Josep Tabernero, Cathy Eng